Inhaled drug trial aims to clear stubborn lung bugs
Disease control
Terminated
This study tested whether adding an inhaled antibiotic called clofazimine to standard treatment could help people with a persistent lung infection caused by nontuberculous mycobacteria (NTM). The main goals were to see if the inhaled drug could clear the bacteria from the lungs a…
Phase: PHASE3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC